Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/28/1993 | CA1322553C Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds |
09/28/1993 | CA1322552C Anxiolytic-r-n(1-azabicyclo[2.2.2)oct-3-yl) benzamides and thiobenzamides |
09/28/1993 | CA1322531C Phenolic thioethers as inhibitors of 5-lipoxygenase |
09/28/1993 | CA1322530C Composition for treating alzheimer's disease containing l-deprenyl |
09/28/1993 | CA1322529C Dosage form of fenofibrate |
09/28/1993 | CA1322528C Deodorant as well as deodorizing food, drink and luxury |
09/28/1993 | CA1322527C Compositions and methods of effecting contraception |
09/28/1993 | CA1322526C Chemical prevention or reversal of cataract by phase separation inhibitors |
09/28/1993 | CA1322525C Use of 1-benzyl-aminoalkyl-pyrrolidinones as antidepressants |
09/28/1993 | CA1322524C Method and composition for ophthalmic anesthesia using rodocaine |
09/28/1993 | CA1322523C Central nervous system injury treatment with opiate- receptor antagonists |
09/28/1993 | CA1322522C Traumatic and ischemic brain injury treatment with opiate-receptor antagonists |
09/27/1993 | CA2092017A1 Butadiene derivatives and process for preparing the same |
09/27/1993 | CA2091309A1 Antibiotic compounds |
09/26/1993 | CA2090076A1 Method for improving primary memory and/or learning |
09/25/1993 | CA2092276A1 Sulfonamido- and sulfonamidocarbonylpyridine -2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals |
09/25/1993 | CA2091978A1 Pharmaceutical compounds |
09/24/1993 | WO1993018745A1 Use of antiviral coating for latex items such as condoms |
09/24/1993 | CA2108143A1 Use of an antiviral coating for latex viral barrier items such as condoms |
09/24/1993 | CA2092112A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use |
09/24/1993 | CA2092111A1 Anti-ulcer pyridyloxy derivatives, their preparation and uses |
09/24/1993 | CA2092108A1 Halichondrins |
09/23/1993 | EP0571524A4 Peroxyacid bleach precursor compositions. |
09/23/1993 | DE4307883A1 Use of anti-retroviral substances - to treat motor-neuronal diseases |
09/23/1993 | DE4305079A1 Thioctic acid, mesna and flupirtin maleate solid forms |
09/23/1993 | DE4305078A1 Pharmaceutical compsns. for inhalation contg. flezelastin or salts |
09/23/1993 | DE4230876A1 Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten Aerosols under-use of polyoxyethylene glyceryl oleates |
09/23/1993 | DE4208300A1 Medicaments contg. iso:petasin or oxo:petasin - is e.g. for blocking leukotriene synthesis, protecting the gastrointestinal tract or blocking calcium channels |
09/22/1993 | EP0561744A1 Preparations containing chromium and vitamins E and C for controlling carbohydrate and lipid metabolism |
09/22/1993 | EP0561597A1 New derivatives of physostigmine, their use and pharmaceutical formulations containing them |
09/22/1993 | EP0561523A2 Sugar compound, sialic acid-containing sugar chains' biosynthesis inhibitor, production process thereof and intermediate |
09/22/1993 | EP0561424A1 Dehydrated liposomes |
09/22/1993 | EP0561408A1 Agent for treatment of chronic fatigue syndrome |
09/22/1993 | EP0561357A1 Pharmaceutical composition comprising a potassium-channel-opener and an antagonist of angiotensin-II receptors |
09/22/1993 | EP0561330A1 Topical insulin preparation |
09/22/1993 | EP0561307A1 Smoking cessation agent |
09/22/1993 | EP0561296A1 Cyclic aminomethylene bisphosphonate derivatives |
09/22/1993 | EP0561252A1 2-Oxoquinoline derivatives as angiotensin II antagonists |
09/22/1993 | EP0561237A2 Enantiomer, (-)-N-(2-ethoxyphenyl)-N'-(1,2,2-trimethylpropyl)-2-nitromethene-1,1-diamine, process for its preparation and its use |
09/22/1993 | EP0561175A1 Pyrimidine derivatives and pharmaceutical compostions containing them |
09/22/1993 | EP0561166A1 Aerosol compositions containing compound D-18024 and its analogs |
09/22/1993 | EP0561141A1 Highly concentrated amino acid solution |
09/22/1993 | EP0561090A1 Process for the preparation of poor-digestible polysaccharides, possibly hydrogenated |
09/22/1993 | EP0561088A2 Low-cariogenic hydrogenated starch hydrolysate, process for obtaining the same and its use |
09/22/1993 | EP0561073A1 Treatment of ocular hypertension with beta-blockers and derivatives of protanoic acid |
09/22/1993 | EP0560982A1 Process for producing sugar and transfusion |
09/22/1993 | EP0560967A1 Use of aica riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow |
09/22/1993 | EP0560937A1 Pharmaceutical compositions |
09/22/1993 | EP0560929A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
09/22/1993 | EP0560900A1 Prevention of synovial adhesions. |
09/22/1993 | EP0560821A1 Solid dosage forms of almokalant and processes for manufacture thereof |
09/22/1993 | EP0560816A1 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
09/22/1993 | EP0560809A1 Agent for reducing the growth of, or removing, human body hair. |
09/22/1993 | EP0526578A4 Composition and method for topical treatment of damaged or diseased tissue |
09/22/1993 | EP0479781B1 Pharmaceutical composition containing a hydrophilic active compound treated by an organic acid and encapsulated in a liposome |
09/22/1993 | EP0477178B1 Therapeutic composition and kit for the treatment of rhumatoid polyarthritis |
09/22/1993 | EP0474712B1 Lysolecithin derivatives for treating autoimmune diseases |
09/22/1993 | EP0423151B1 Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them |
09/22/1993 | EP0412125B1 Pharmaceutical dosage form for the medication of fish |
09/22/1993 | EP0382842B1 Nootropic |
09/22/1993 | EP0247071B1 Immunotherapeutic treatment |
09/22/1993 | CN1076450A Nitrogen-containing tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use |
09/22/1993 | CN1076449A Imidazopyridine derivatives and drugs thereof |
09/22/1993 | CN1076447A Antitumor compositions and methods of treatment |
09/22/1993 | CN1076446A 哌嗪衍生物 Piperazine derivatives |
09/22/1993 | CN1076445A Supstituted phenylquinazoline derivatives |
09/22/1993 | CN1076444A Imidazolyl-substituted phenylacetamides |
09/22/1993 | CN1076443A Substituted phenylacetamides |
09/22/1993 | CN1076441A Process for preparing fibrinogen receptor antagonists |
09/22/1993 | CN1076439A New compounds |
09/22/1993 | CN1076358A Methods and compositions for reducing multi-drug resistance |
09/22/1993 | CN1076357A Pharmaceutical composition |
09/22/1993 | CN1022187C Method for preparation of tricyclic compounds |
09/22/1993 | CN1022186C Method for preparation of diaza-dicyclic compound |
09/22/1993 | CN1022184C Process for preparing (1 H-imidzol-1-ylmethyl) substituted benzotriazole derivatives |
09/21/1993 | USRE34387 Administering 5-amino-4-imidazolecarboxamide |
09/21/1993 | US5247123 Vitamin D intermediate, for skin disorders |
09/21/1993 | US5247102 Cyclization of a resorcinol derivative with ethyl orthoformate in the presence of a base |
09/21/1993 | US5247079 Chemical intermediates for tranquilizers |
09/21/1993 | US5247076 Imidazolidyl macrolides having immunosuppressive activity |
09/21/1993 | US5246971 Method of inhibiting nitric oxide formation |
09/21/1993 | US5246970 Administering aminoguanidine |
09/21/1993 | US5246967 Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies |
09/21/1993 | US5246966 Substituted alkenoic acid and its derivatives |
09/21/1993 | US5246964 Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters |
09/21/1993 | US5246958 Antihypertensive thiocarbamoylascetonitrile compounds |
09/21/1993 | US5246957 N-imidazolyl derivatives of substituted indole |
09/21/1993 | US5246956 N-imidazolyl derivatives of substituted alkoxyimino tetrahydronaphthalenes and chromans having antithromboxane a2 activity |
09/21/1993 | US5246955 Antineoplastic compounds and methods of using same |
09/21/1993 | US5246952 Heteroarylmethylbenzenes |
09/21/1993 | US5246951 Nonsteroidal antiinflammatory agents |
09/21/1993 | US5246950 Thioformamide derivatives |
09/21/1993 | US5246949 Preparation for endermism containing dopamine derivatives |
09/21/1993 | US5246945 Piperidine derivatives |
09/21/1993 | US5246944 Hypotensive and anxiolytic agents; antidepressants |
09/21/1993 | US5246943 Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
09/21/1993 | US5246941 Serotonin antagonist |
09/21/1993 | US5246940 Substituted n-biphenylyl lactams |
09/21/1993 | US5246939 Antiadrenergic systems for lower urinary apparatus |
09/21/1993 | US5246935 Piperazinyl derivatives and methods of treating central nervous system ailments relating to the 5-ht2 receptor system |